This chemical is primarily used in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of compounds targeting various therapeutic areas, including central nervous system disorders and metabolic diseases. Its structure, featuring a trifluoromethyl group and a pyrrolidine ring, is valuable for enhancing the biological activity and metabolic stability of drug candidates. Additionally, it is employed in medicinal chemistry for the design and optimization of small molecule drugs, leveraging its potential to improve drug-like properties such as solubility and bioavailability.